Published as part of the Special Topic Modern Radical Methods and their Strategic Applications in Synthesis
Key words
quaternary center - bridgehead hydroxy - Cp
2TiCl - bicyclic lactone - radical cyclization - Tamao–Fleming oxidation
The development of methodologies that employ reactive species that enable the synthesis of valuable molecules and advanced synthons owing to their unique reactivity is of significant importance in synthetic organic chemistry. A plethora of useful and elegant chemistry has been developed over the years using radical intermediates, despite the accepted notion that these species are chaotic, uncontrollable, and non-stereoselective.[1]
[2]
In these endeavors, methods based on Cp2Ti(III)Cl[3] mediated radical epoxide-opening reactions, first reported by Nugent and RajanBabu,[4] have been used by several research groups, including ours, as the key step in the synthesis of many natural products[5]
[6]
[7] and medicinally relevant compounds.[8,9] We began our journey with Cp2Ti(III)Cl with the development of an iterative synthetic strategy that allowed the synthesis of chiral 2-methyl-1,3-diols by selective opening of a trisubstituted chiral 2,3-epoxy alcohol at the more substituted carbon.[10] The designed tactic was extended later in the stereoselective construction of chiral quaternary stereocenters by trapping the radical intermediate with suitable acceptors, particularly in an intramolecular mode, to provide carbocycles,[11] oxacycles,[12] azacycles,[13] and dioxafenestranes.[14]
After successful implementation of the titanocene(III) chemistry for the construction of quaternary centers, we next intended to extend our iterative methodology to build hydroxylated bridgehead chiral centers in bicyclic ring systems, structural features of various natural products and natural product inspired synthons.[15]
Figure 1 Bioactive natural products containing hydroxylated bridgehead chiral centers in bicyclic ring systems and our designed β-hydroxy cyclopentano lactone
As the process of isolation, structure elucidation, and biological evaluation of new natural products is rather laborious and time consuming, the concept of the development of natural product hybrids and analogues, containing two or more different pharmacophoric subunits, is being actively pursued.[16] Cyclopentano-monoterpene lactone 1 represents one of the parent frameworks common to a large number of plant families and in various species of Iridomyrmex
[17] known to exhibit highly excitative activity towards cats and other Felidae animals and used by ants as agents of defense against preying insects.[18] Insertion of a bridgehead hydroxy group into the core scaffold of 1 leads to the structure 6, which can be regarded as a biologically pre-validated scaffold owing to the fact that many natural products based on this hydroxylated bicyclic ring system possess a wide array of densely functionalized structures 2–5
[15]
[19] with diverse biological activities (Figure [1]).
Herein, we disclose the viability of the Ti(III)-mediated reductive epoxide opening–cyclization sequence to build hydroxylated bridgehead stereogenic centers following two approaches summarized in Scheme [1]. The direct approach (A) employing an epoxy-β-alkoxy-α,β-unsaturated ester was backed up by an alternate strategy (B) starting with an epoxy-β-(triorganosilyl)-α,β-unsaturated ester in which the silyl group could serve as a surrogate for the eventual oxygen functionality. The stereoretentive oxidative cleavage of the C–Si bond using the Tamao–Fleming method[20] was expected to provide a synthetic strategy to access the desired bridgehead-oxygenated bicyclic ring systems (Scheme [1]). We report here the full detail of our systematic study toward the target scaffold.
Scheme 1 Generalized scheme of our approach
To evolve an approach efficaciously, at the outset, we devised a simple strategy to access epoxide 7 with a tethered enol ether serving as a precursor for the key Ti(III)-mediated reductive epoxide opening–cyclization to access the bridgehead-oxygenated bicyclic ring in one go (Scheme [1], A).
Scheme 2 Preparation of the epoxide 13
The reaction of the dianion of ethyl acetoacetate (11) with 4-bromobut-1-ene afforded ethyl 3-oxooct-7-enoate (12) by following the procedure documented in literature (Scheme [2]).[21]
Table 1 Attempted Preparation of the Silyl Enol Ethera
|
|
Entry
|
Reagents
|
Solvent
|
Product
|
Yield (%)b
|
|
1
|
DIPEA/TBSOTf
|
CH2Cl2
|
14
|
88
|
|
2
|
K2CO3/18-crown-6/TBSOTf
|
THF
|
14
|
72
|
|
3
|
Et3N/TBSOTf
|
CH2Cl2
|
14
|
81
|
|
4
|
imidazole/TBSCl
|
toluene
|
–
|
–c
|
|
5
|
DBU/TBSCl
|
CH2Cl2
|
–
|
–c
|
|
6
|
2,6-lutidine/TBSOTf
|
CH2Cl2
|
15
|
63
|
|
7
|
Et3N/TBSOTf
|
hexane
|
15
|
57
|
a Reaction conditions: 13 (1.0 equiv), base (2.0 equiv), silylating agent (1.5 equiv), solvent (3 mL/mmol).
b Isolated yield after silica gel column chromatography.
c No reaction; starting material was recovered.
Next, epoxide 13 was synthesized from 12 in 87% yield using m-CPBA (Scheme [2]) and was subsequently subjected to various reaction conditions to deliver the desired silyl enol ether 7a. A summary of these efforts using different bases and additives is documented in Table [1].
To begin with, when epoxide 13 was treated with DIPEA/TBSOTf in CH2Cl2 for 12 h, it furnished an unusual bicyclic ketal moiety 14
[22] (Table [1], entry 1), failing to provide the desired silyl enol ether 7a. The use of K2CO3/18-crown-6/TBSOTf in THF and Et3N/TBSOTf in CH2Cl2 led to the same result (Table [1], entries 2 and 3). Treatment of 13 with TBSCl/imidazole or TBSCl/DBU did not initiate any reaction and led to the recovery of starting material (Table [1], entries 4 and 5). Whereas formation of the THP derivative 15 (E/Z 1:5) resulted from the use of 2,6-lutidine and Et3N with TBSOTf in CH2Cl2 and hexane, respectively (Table [1], entries 6 and 7).
Scheme 3 Preparation of the protected enol ethers 7a–d
Gratifyingly, the reaction occurred to produce the desired silyl enol ether 7a in 81% yield when epoxide 13 in CH2Cl2 was stirred with Et3N/HMPA/TBSOTf/DMAP at room temperature for 12 h (Scheme [3]). The synthesis of the epoxide with a tethered enol ether 7a set the stage for the implementation of our crucial epoxide opening–cyclization step.
Table 2 Ti(III)-Mediated Reductive Cyclization of Epoxy Estersa
|
|
Entry
|
Compound (PG)
|
Product
|
Yield (%)b
|
|
1
|
7a (TBS)
|
16
|
72
|
|
2
|
7b (Boc)
|
17
|
43
|
|
3
|
7c (Ts)
|
17
|
47
|
|
4
|
7d (Bz)
|
complex mixture
|
–c
|
a Reaction conditions: epoxide (1.0 equiv), Cp2TiCl2 (3.0 equiv), Zn (9.0 equiv), THF (45 mL/mmol).
b Isolated yield after silica gel column chromatography.
c Not determined.
Compound 7a failed to undergo reductive epoxide cleavage mediated by [Cp2Ti(III)Cl] with cyclization onto the pendant enol ether and instead provided the deoxygenated product 16 (Table [2], entry 1). The outcome sheds light onto the fact that the occupancy of the O-silyl group probably made the β-carbon less prone to the radical attack. With the aim to optimize the electron density at the β-carbon, it was decided to switch to the acetyl enol carbonate 7b, enol sulfonate ester 7c, and enol ester 7d following the optimum conditions developed for 7a using (Boc)2O, TsCl, and BzCl, respectively (Scheme [3]).
Compounds 7b–d were subjected to the key Cp2Ti(III)Cl-mediated reductive epoxide cleavage and radical cyclization (Table [2], entries 2–4). Optimization of the electron density at the β-carbon with the aim to achieve the cyclize product worked out for 7b and 7c, but with the loss of the oxygen functionality present at the β-carbon leading to the formation of cyclopentylidene derivative 17.[23] While subjection of 7d to the Cp2TiCl-reaction resulted in a complex mixture of products.
The failure to furnish the expected bicyclic lactone 6 with a bridgehead hydroxy group directly from 7 led us to try the alternative route starting with the epoxy-β-(triorganosilyl)-α,β-unsaturated ester 9 in which the silyl group was expected to serve as a surrogate for the bridgehead oxygen functionality (Scheme [1], B).
Scheme 4 Preparation of the epoxy esters
Synthesis of 9 started with 1,3-dithiane (18) which, following a modified literature procedure,[24a]
[b] was silylated with triorganosilyl chloride followed by alkylation using 5-bromopent-1-ene to deliver the dithianes 19a and 19b in one pot. The desired acylsilane 20a was synthesized by a reported procedure[24a] using the oxidizing agent CAN, while 20b
[24c]
[d] resulted with a poor yield. After investigating a number of alternative methods, removal of the thioketal was performed using CaCO3/MeI (Scheme [4]).[25] The Peterson olefination reaction[26] of acylsilanes 20a and 20b with the lithium enolate of ethyl (trimethylsilyl)acetate produced the (Z)-α,β-unsaturated ester predominantly together with an inseparable mixture the of E-isomer and residual reagents (21a E/Z = 1:7; 21b E/Z = 1:9). Exploration of the Horner–Wadsworth–Emmons reaction[27] on 20a using triethyl phosphonoacetate also gave the required product, but with reverse stereoselectivity (21a E/Z = 4:1) and in lower yield (53%). Among the alternate possible routes available for the synthesis of 21b, hydrosilylation reaction of ethyl oct-7-en-2-ynoate[28] with PhMe2SiH catalyzed by cyclopentadienyl-ruthenium complex [Cp*Ru(MeCN)3]PF6 was also explored.[29] But for scaling up purposes, we continued with the route depicted in Scheme [4]. With better stereoselectivity and yield, the crude products of Peterson olefination reaction 21a and 21b were subjected to epoxidation with m-CPBA which resulted in a separable mixture of the pure (Z)-epoxy-α,β-unsaturated esters 9a and 9b (Z-isomer 9a = 60%, E-isomer 9a′ = 10%; Z-isomer 9b = 61%, E-isomer 9b′ = 9%) (Scheme [4]).
Scheme 5 Ti(III)-mediated reductive epoxide opening and radical cyclization
Next, the Z-isomers 9a and 9b were subjected to reductive epoxide cleavage mediated by Cp2Ti(III)Cl (generated in situ from Cp2TiCl2and activated Zn dust) with concomitant 5-exo-trig cyclization onto the pendant β-silyl-α,β-unsaturated ester to successfully give the bicyclic lactones with the cis ring junction embedded with bridgehead C–Si bond 10a and 10b (Scheme [5]) in good yields. Further, inspection of the stereochemical outcome led us to set up the Cp2Ti(III)Cl reaction also with the E-isomer 9a′. 1H NMR and 13C NMR of the product from the reaction of the E-isomer 9a′ showed that it was identical to that from the Z-isomers 9a and 9b. NOE experiments were carried out to establish the stereochemical outcome of the ring junction (see the Supporting Information).
Scheme 6 Construction of the hydroxy-substituted quaternary center
The next crucial step was the Tamao–Fleming oxidation,[20] which permits silyl group to be used as ‘masked hydroxy group’. Although the TMS group shows extremely high tolerability to a range of reaction conditions, its use in Tamao–Fleming oxidation is limited. The single step reaction protocol documented in the literature for this transformation using TBHP and KH[30] failed to install the bridgehead hydroxy group in 10a, although it was effective for other molecular frameworks. The same conversion of the TMS group into the hydroxy group could possibly be achieved in a multistep sequence through a recently reported procedure which involves an initial iridium-catalyzed C(sp3)–H borylation of the methyl group on silicon.[31]
An alternate two-step protocol, shown in Scheme [6], required the use of the dimethylphenylsilyl group in place of trimethylsilyl. To render this transformation, the non-hydrolysable dimethylphenylsilane in 10b was first activated to a fluorosilane 22 followed by the oxidation of the resulting functionalized silicon atom using H2O2 to install the desired bridgehead hydroxyl group to furnish hydroxylated-cyclopentano lactone 6 in 93% overall yield. The stereostructure of 6 was confirmed by 2D NMR and NOE studies (see the Supporting Information).
Subsequently, an extension of the aforementioned strategy to access 6,6-fused ring systems was also attempted. In this regard, the requisite epoxy-β-(triorganosilyl)-α,β-unsaturated ester was synthesized by dimethylphenylsilylation of 1,3-dithiane, alkylation using 6-bromohex-1-ene and then following the same strategy used for synthesizing compound 9 as shown in Scheme [4]. However, implementation of the key Cp2Ti(III)Cl-mediated reaction resulted in a mixture of deoxygenated and reduced products with no trace of the required 6,6-fused bicyclic product.
In conclusion, as part of our ongoing research endeavor, we successfully widen the viability of Ti(III)-mediated epoxide opening cyclization protocol to forge a hydroxylated bridgehead chiral center, the structural feature observed in a countless number of natural products and natural product inspired synthons. The β-silyl functionality turned out to be very effective to fix the bridgehead stereocenters in the 6,5-fused bicyclic β-hydroxy lactone and serve as a valuable synthon for later stage functionalization to give the hydroxy group and build the desired hydroxylated bridgehead stereocenter with excellent diastereoselectivity and in reasonable overall yield, amenable to scale up. Further application of the strategy will be demonstrated in due course by the successful synthesis of natural products containing similar 6,5-fused ring systems.
All the reactions were carried out under an inert atmosphere in oven-dried glassware using dry solvents, unless otherwise stated. All chemicals purchased from commercial suppliers were used as received unless otherwise stated. Reactions and chromatography fractions were monitored by Merck silica gel 60 F-254 glass TLC plates and visualized using UV light, 7% ethanolic phosphomolybdic acid/heat or 2.5% ethanolic anisaldehyde (with 1% AcOH and 3.3% concd H2SO4)/heat as developing agents. Flash column chromatography was performed with 100–200 mesh silica gel and yields refer to chromatographically and spectroscopically pure compounds.
All NMR spectra were recorded in CDCl3 or in DMSO-d
6 on a 400 MHz instrument at 300 K and are calibrated to residual solvent peaks [CHCl3 δ = 7.26 (1H) and 77.0 (13C), DMSO δ = 2.50 (1H) and 40.0 13C). FT-IR spectra were recorded as neat liquid or KBr pellets using PerkinElmer Spectrum BX spectrophotometer. HRMS was performed on Micromass Q-TOF Micro instrument.
Ethyl 7,8-Epoxy-3-oxooctanoate (13)
Ethyl 7,8-Epoxy-3-oxooctanoate (13)
To a solution of 12 (1.0 g, 5.43 mmol, 1.0 equiv) in CH2Cl2 (15 mL) at 0 °C was added portionwise m-CPBA (77%, 2.43 g, 10.86 mmol, 2.0 equiv); the mixture was warmed to r.t. and stirred for 3.5 h. The reaction was then quenched with sat. aq Na2SO3 and extracted with EtOAc. The combined extracts were washed with sat. aq NaHCO3 solution, water, and brine, dried (anhyd Na2SO4), and concentrated. Purification by column chromatography [silica gel, 20% EtOAc/hexane; Rf
= 0.52 (silica gel, 40% EtOAc/hexane)] afforded epoxide 13 (945 mg, 87%) as a colorless oil.
IR (neat): 3403, 2983, 2934, 1742, 1715, 1638, 1318, 1022 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 4.18 (q, J = 7.1 Hz, 2 H), 3.43 (s, 2 H), 2.91–2.86 (m, 1 H), 2.75–2.71 (m, 1 H), 2.65–2.59 (m, 2 H), 2.45 (dd, J = 4.9, 2.7 Hz, 1 H), 1.81–1.73 (m, 2 H), 1.67–1.59 (m, 1 H), 1.49–1.39 (m, 1 H), 1.26 (t, J = 7.1 Hz, 3 H).
13C NMR (CDCl3, 100 MHz): δ = 202.34, 167.15, 61.35, 51.88, 49.28, 46.71, 42.27, 31.48, 19.85, 14.05.
HRMS (ESI): m/z [M + Na]+ calcd for C10H16O4Na: 223.0946; found: 223.0944.
Ethyl 6,8-Dioxabicyclo[3.2.1]octan-5-ylacetate (14); General Procedure
Ethyl 6,8-Dioxabicyclo[3.2.1]octan-5-ylacetate (14); General Procedure
To a solution of 13 (1.0 equiv) in CH2Cl2 or in THF (3 mL/mmol) at 0 °C were added Et3N (2 equiv), DIPEA (2 equiv), or K2CO3 (2.0 equiv)/18-crown-6 (2.0 equiv) and TBSOTf (1.5 equiv). Then the mixture was stirred at r.t. for 12 h and quenched with sat. aq NH4Cl. The mixture was extracted with EtOAc and the combined extracts were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. Purification by column chromatography [silica gel, 15% EtOAc/ hexane; Rf
= 0.43 (silica gel, 32% EtOAc/hexane)] afforded 14 (72–88%) as a colorless oil.
IR (neat): 3432, 2943, 2859, 2361, 1731, 1643, 1451, 1367, 1253, 1171, 1109, 1028 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 4.58–4.54 (m, 1 H), 4.16 (q, J = 7.1 Hz, 2 H), 3.95–3.91 (m, 1 H), 3.88–3.83 (m, 1 H), 2.73 (s, 2 H), 1.96–1.74 (m, 4 H), 1.69–1.60 (m, 1 H), 1.51–1.44 (m, 1 H), 1.26 (t, J = 7.1 Hz, 3 H).
13C NMR (CDCl3, 100 MHz): δ = 169.07, 106.37, 75.10, 69.10, 60.55, 43.44, 33.76, 27.93, 16.65, 14.15.
HRMS (ESI): m/z [M + Na]+ calcd for C10H16O4Na: 223.0946; found: 223.0948.
Ethyl 6-[(tert-Butyldimethylsiloxy)methyl]tetrahydro-2H-pyran-2-ylideneacetate (15); General Procedure
Ethyl 6-[(tert-Butyldimethylsiloxy)methyl]tetrahydro-2H-pyran-2-ylideneacetate (15); General Procedure
To a solution of 13 (1.0 equiv) in CH2Cl2 or hexane (3 mL/mmol) at 0 °C were added 2,6-lutidine (2.0 equiv) or Et3N (2.0 equiv) and TBSOTf (1.5 equiv). Then the mixture was stirred at r.t. for 12 h and quenched with sat. aq NH4Cl. The mixture was extracted with EtOAc and the combined extracts were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. Purification by flash column chromatography [silica gel, 15% EtOAc/hexane; Rf
= 0.60 (silica gel, 10% EtOAc/hexane)] gave 15 (57–63%) as a colorless oil.
IR (neat): 3439, 2924, 2852, 2361, 1729, 1644, 1460, 1369, 1279, 1252, 1166, 1028 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 4.67–4.60 (m, 1 H), 4.14 (q, J = 7.1 Hz, 2 H), 3.91–3.84 (m, 1 H), 3.73 (dd, J = 10.5, 5.2 Hz, 1 H), 3.62 (dd, J = 10.5, 6.0 Hz, 1 H), 2.99 (br s, 2 H), 2.16–1.96 (m, 2 H), 1.90–1.76 (m, 1 H), 1.64–1.52 (m, 1 H), 1.25 (t, J = 7.1 Hz, 3 H), 0.88 (s, 9 H), 0.05 (s, 6 H).
13C NMR (CDCl3, 100 MHz): δ = 170.54, 147.49, 98.89, 76.09, 65.26, 60.67, 40.34, 25.86, 23.55, 19.78, 18.33, 14.15, –5.30, –5.35.
HRMS (ESI): m/z [M + Na]+ calcd for C16H30O4SiNa: 337.1811; found: 337.1815.
Ethyl (E)-3-(tert-Butyldimethylsiloxy)-7,8-epoxyoct-2-enoate (7a)
Ethyl (E)-3-(tert-Butyldimethylsiloxy)-7,8-epoxyoct-2-enoate (7a)
To a stirred solution of 13 (100 mg, 0.5 mmol, 1.0 equiv) in CH2Cl2 (2.5 mL) at r.t., Et3N (0.42 mL, 3.0 mmol, 6.0 equiv) and HMPA (0.4 mL) were added. After 15 min, TBSOTf (0.23 mL, 1.0 mmol, 2.0 equiv) and DMAP (12 mg, 0.1 mmol, 0.2 equiv) were added sequentially. After stirring for 12 h at r.t., the mixture was quenched with sat. aq NH4Cl and extracted with Et2O. The combined organic layers were washed with 1 M aq HCl, water, and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The resulting residue [Rf
= 0.43 (silica gel, 20% EtOAc/hexane)] was subjected to the Cp2TiCl-mediated cyclization reaction without any further purification.
Ethyl (E)-3-(tert-Butoxycarbonyloxy)-7,8-epoxyoct-2-enoate (7b)
Ethyl (E)-3-(tert-Butoxycarbonyloxy)-7,8-epoxyoct-2-enoate (7b)
To a stirred solution of 13 (100 mg, 0.5 mmol, 1.0 equiv) in CH2Cl2 (2.5 mL) at r.t., Et3N (0.21 mL, 1.5 mmol, 3.0 equiv) and HMPA (0.2 mL) were added. After 15 min, Boc2O (0.23 mL, 1.0 mmol, 2.0 equiv) and DMAP (12 mg, 0.1 mmol, 0.2 equiv) were added sequentially. After stirring for 5 h at r.t., the mixture was quenched with sat. aq NH4Cl and extracted with Et2O. The combined organic layers were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The resulting residue was purified by flash column chromatography [silica gel, 10% EtOAc/hexane; Rf
= 0.70 (silica gel, 20% EtOAc/hexane)] to afford 7b (113 mg, 75%) as a colorless liquid.
IR (neat): 3419, 2361, 1763, 1644, 1456, 1399, 1372, 1253, 1221, 1114, 1017 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 5.79 (s, 1 H), 4.16 (q, J = 7.1 Hz, 2 H), 2.96–2.85 (m, 3 H), 2.76–2.72 (m, 1 H), 2.47 (dd, J = 4.9, 2.6 Hz, 1 H), 1.79–1.55 (m, 4 H), 1.51 (s, 9 H), 1.27 (t, J = 7.1 Hz, 3 H).
13C NMR (CDCl3, 100 MHz): δ = 166.04, 165.92, 150.10, 109.46, 84.08, 60.23, 51.86, 47.02, 31.78, 30.36, 27.57, 23.12, 14.18.
HRMS (ESI): m/z [M + Na]+ calcd for C15H24O6Na: 323.1471; found: 323.1476.
Ethyl (E)-7,8-Epoxy-3-(tosyloxy)oct-2-enoate (7c)
Ethyl (E)-7,8-Epoxy-3-(tosyloxy)oct-2-enoate (7c)
To a stirred solution of 13 (100 mg, 0.5 mmol, 1.0 equiv) in CH2Cl2 (2.5 mL) at r.t., Et3N (0.21 mL, 1.5 mmol, 3.0 equiv) and HMPA (0.2 mL) were added. After 15 min, TsCl (143 mg, 0.75 mmol, 1.5 equiv) and DMAP (12 mg, 0.1 mmol, 0.2 equiv) were added sequentially. After stirring for 12 h at r.t., the mixture was quenched with sat. aq NH4Cl and extracted with Et2O. The combined organic layers were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The resulting residue was purified by flash column chromatography [silica gel, 8% EtOAc/hexane; Rf
= 0.50 (silica gel, 40% EtOAc/ hexane)] to afford 7c (126 mg, 71%) as a light-yellow oil.
IR (neat): 3435, 2929, 2361, 1719, 1650, 1596, 1455, 1373, 1218, 1185, 1122, 1032, 980, 879 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 7.85–7.80 (m, 2 H), 7.40–7.36 (m, 2 H), 5.82 (s, 1 H), 4.14 (q, J = 7.1 Hz, 2 H), 2.89–2.82 (m, 1 H), 2.79–2.73 (m, 2 H), 2.73–2.70 (m, 1 H), 2.47 (s, 3 H), 2.42 (dd, J = 5.0, 2.6 Hz, 1 H), 1.70–1.41 (m, 4 H), 1.26 (t, J = 7.1 Hz, 3 H).
13C NMR (CDCl3, 100 MHz): δ = 165.22, 165.10, 145.83, 132.82, 130.00, 128.19, 110.13, 60.55, 51.70, 46.91, 31.52, 30.92, 22.79, 21.72, 14.10.
HRMS (ESI): m/z [M + Na]+ calcd for C17H22O6SNa: 377.1035; found: 377.1036.
Ethyl (E)-3-(Benzoyloxy)-7,8-epoxyoct-2-enoate (7d)
Ethyl (E)-3-(Benzoyloxy)-7,8-epoxyoct-2-enoate (7d)
To a stirred solution of 13 (100 mg, 0.5 mmol, 1.0 equiv) in CH2Cl2 (2.5 mL) at r.t., Et3N (0.21 mL, 1.5 mmol, 3.0 equiv) and HMPA (0.2 mL) were added. After 15 min, BzCl (0.12 mL, 1.0 mmol, 2.0 equiv) and DMAP (12 mg, 0.1 mmol, 0.2 equiv) were added sequentially. After stirring for 4 h at r.t., the mixture was quenched with sat. aq NH4Cl and extracted with Et2O. The combined organic layers were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The resulting crude (mixture of E/Z isomer 14:1) was purified by flash column chromatography [silica gel, 5% EtOAc/hexane; Rf
= 0.43 (silica gel, 20% EtOAc/hexane)] to afford 7d (E-isomer) (131 mg, 86%) as a light-yellow oil.
IR (neat): 3424, 2361, 1739, 1717, 1647, 1453, 1372, 1254, 1224, 1179, 1122, 1088, 1020 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 8.09–8.05 (m, 2 H), 7.66–7.60 (m, 1 H), 7.52–7.46 (m, 2 H), 5.85 (s, 1 H), 4.19 (q, J = 7.1 Hz, 2 H), 3.06–2.97 (m, 2 H), 2.96–2.90 (m, 1 H), 2.74 (t, J = 4.5 Hz, 1 H), 2.46 (dd, J = 4.9, 2.7 Hz, 1 H), 1.86–1.54 (m, 4 H), 1.29 (t, J = 7.1 Hz, 3 H).
13C NMR (CDCl3, 100 MHz): δ = 166.47, 165.74, 163.89, 133.88, 130.08, 128.89, 128.66, 110.77, 60.28, 51.85, 47.03, 31.87, 30.66, 23.17, 14.19.
HRMS (ESI): m/z [M + Na]+ calcd for C17H20O5Na: 327.1208; found: 327.1208.
Cp2TiCl-Mediated Radical Cyclization of 7a–d, 9a,b and 9a′; General Procedure
Cp2TiCl-Mediated Radical Cyclization of 7a–d, 9a,b and 9a′; General Procedure
In a flame-dried round-bottom flask containing THF (30 mL/mmol) were added Zn (9.0 equiv) and Cp2TiCl2 (3.0 equiv) under an inert atmosphere and the mixture was stirred for 1 h at r.t. (the color changed from deep red to green). The epoxide (1.0 equiv) in THF (15 mL/mmol) was cannulated into this solution at r.t. under N2 atmosphere. The mixture was brought to r.t. and continuously stirred for 40 h. The mixture was quenched with sat. aq NH4Cl and stirred for an additional 15 min. The solvent was evaporated in vacuo and the residue was extracted with Et2O; the combined extracts were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. Purification by column chromatography (silica gel) afforded the product.
Ethyl (E)-3-(tert-Butyldimethylsiloxy)octa-2,7-dienoate (16)
Ethyl (E)-3-(tert-Butyldimethylsiloxy)octa-2,7-dienoate (16)
Following the general procedure using 7a (90 mg, 0.29 mmol) with purification by column chromatography [100–200 mesh silica gel, 5% EtOAc/hexane; Rf
= 0.80 (silica gel, 20% EtOAc/hexane)] gave 16 as a colorless oil; yield: 62 mg (72%).
IR (neat): 3443, 2930, 2361, 1709, 1626, 1464, 1368, 1259, 1134, 1044, 913, 837 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 5.87–5.76 (m, 1 H), 5.07 (s, 1 H), 5.04–4.92 (m, 2 H), 4.11 (q, J = 7.1 Hz, 2 H), 2.76–2.70 (m, 2 H), 2.09 (dd, J = 14.6, 7.1 Hz, 2 H), 1.68–1.59 (m, 2 H), 1.26 (t, J = 7.1 Hz, 3 H), 0.94 (s, 9 H), 0.23 (s, 6 H).
13C NMR (CDCl3, 100 MHz): δ = 173.18, 167.67, 138.46, 114.66, 99.05, 59.27, 33.35, 32.81, 26.27, 25.45, 18.04, 14.39, –4.67.
HRMS (ESI): m/z [M + Na]+ calcd for C16H30O3SiNa: 321.1862; found: 321.1863.
Ethyl 2-(Hydroxymethyl)cyclopentylideneacetate (17)
Ethyl 2-(Hydroxymethyl)cyclopentylideneacetate (17)
Following the general procedure using 7b (80 mg, 0.27 mmol) or 7c (80 mg, 0.22 mmol) with purification by column chromatography [100–200 mesh silica gel, 15% EtOAc/hexane; Rf
= 0.40 (silica gel, 20% EtOAc/hexane)] gave 17 as a colorless oil; yield: 22 mg (43% from 7b); 23 mg (47% from 7c).
IR (neat): 3436, 2959, 2361, 1709, 1647, 1463, 1371, 1201, 1129, 1032, 957, 863 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 5.83 (dd, J = 4.5, 2.2 Hz, 1 H), 4.15 (q, J = 7.1 Hz, 2 H), 3.71–3.62 (m, 2 H), 3.00–2.89 (m, 1 H), 2.81–2.68 (m, 2 H), 1.95–1.78 (m, 2 H), 1.72–1.56 (m, 2 H), 1.28 (t, J = 7.1 Hz, 3 H).
13C NMR (CDCl3, 100 MHz): δ = 168.27, 166.77, 112.69, 64.46, 59.66, 48.91, 33.14, 28.67, 24.26, 14.29.
HRMS (ESI): m/z [M + Na]+ calcd for C10H16O3Na: 207.0997; found: 207.0995.
2-(Pent-4-enyl)-2-(silyl)-1,3-dithianes (19a and 19b)
2-(Pent-4-enyl)-2-(silyl)-1,3-dithianes (19a and 19b)
Dithianes 19a and 19b were synthesized by modifying the literature procedure.[24a]
[b] A solution of 1,3-dithiane (3.0 g, 24.95 mmol, 1.0 equiv) in dry THF (75 mL) was cooled to –78 °C and treated with 1.3 M n-BuLi in hexane (20.2 mL, 26.2 mmol, 1.05 equiv). After stirring for 30 min at 0 °C, the solution was cooled to –78 °C and treated with TMSCl (3.5 mL, 27.44 mmol, 1.1 equiv) or Me2PhSiCl (4.6 mL, 27.44 mmol, 1.1 equiv). The resulting solution was stirred for 2 h at r.t. and then cooled to –78 °C, and additional of n-BuLi (20.2 mL) was added. After stirring for 30 min at 0 °C, the solution was cooled to –78 °C and treated with 5-bromopent-1-ene (3.6 mL, 29.94 mmol, 1.2 equiv). Then the mixture was warmed to r.t. and stirred for 12 h. The reaction was quenched with sat. aq NH4Cl and extracted with Et2O. The combined organic layers were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The resulting residue was purified by chromatography (neutral alumina, 5% EtOAc/hexane) to afford 19a (5.6 g, 87%) or 19b [6.9 g, 83%; Rf
= 0.63, (silica gel, 8% EtOAc/hexane)] as light-yellow oils.
Data for 19a
The spectroscopic data were in full accord with those reported in the literature.[24a]
[b]
Data for 19b
IR (neat): 3739, 2314, 1645, 1543, 1516, 1421, 1253, 1111, 912, 821 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 7.69–7.64 (m, 2 H), 7.43–7.34 (m, 3 H), 5.78–5.67 (m, 1 H), 4.99–4.91 (m, 2 H), 3.01–2.92 (m, 2 H), 2.47–2.39 (m, 2 H), 2.12–2.06 (m, 2 H), 2.05–1.95 (m, 3 H), 1.94–1.82 (m, 1 H), 1.55–1.45 (m, 2 H), 0.53 (s, 6 H).
13C NMR (CDCl3, 100 MHz): δ = 138.41, 135.58, 134.79, 129.55, 127.55, 114.77, 39.00, 36.59, 33.94, 26.59, 24.85, 23.68, –3.94.
HRMS (ESI): m/z [M + Na]+ calcd for C17H26S2SiNa: 345.1143; found: 345.1145.
Hex-5-enoyltrimethylsilane (20a)
Hex-5-enoyltrimethylsilane (20a)
Acylsilane 20a was synthesized by using CAN following the literature procedure[24a] and the spectroscopic data were in full accord with those reported.
Hex-5-enoyldimethylphenylsilane (20b)
Hex-5-enoyldimethylphenylsilane (20b)
To a solution of 19b (3.0 g, 9.3 mmol, 1.0 equiv) in CH3CN/H2O (4:1, 50 mL) were added CaCO3 (2.79 g, 27.9 mmol, 3.0 equiv) and MeI (11.5 mL, 186 mmol, 20.0 equiv). After stirring at r.t. for 12 h, the resulting mixture was diluted with Et2O and H2O. The layers were separated, and the aqueous layer was extracted with Et2O. The combined organic layers were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo. The resulting crude was purified by flash column chromatography [silica gel, 5% EtOAc/hexane; Rf
= 0.50 (silica gel, 5% EtOAc/hexane)] to afford the acylsilane 20b (1.75 g, 81%) as a light-yellow oil (synthesis adapted from ref. 25).
IR (neat): 3072, 2933, 1726, 1641, 1429, 1251, 1111, 997, 912, 831 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 7.57–7.52 (m, 2 H), 7.43–7.32 (m, 3 H), 5.74–5.61 (m, 1 H), 4.95–4.88 (m, 2 H), 2.61–2.54 (m, 2 H), 1.98–1.89 (m, 2 H), 1.61–1.51 (m, 2 H), 0.48 (m, 6 H).
13C NMR (CDCl3, 100 MHz): δ = 246.21, 138.09, 134.46, 133.94, 129.84, 128.12, 114.94, 47.85, 33.04, 21.13, –4.78.
HRMS (ESI): m/z [M + Na]+ calcd for C14H20OSiNa: 255.1181; found: 255.1184.
Ethyl (E/Z)-3-(Trimethylsilyl)octa-2,7-dienoate (21a) by HWE Olefination
Ethyl (E/Z)-3-(Trimethylsilyl)octa-2,7-dienoate (21a) by HWE Olefination
A mixture of triethyl phosphonoacetate (278 mg, 1.24 mmol, 2.1 equiv) and NaH (60%, 47 mg, 1.18 mmol, 2.0 equiv) in THF (3 mL) was stirred at 0 °C for 1 h. Then the solution of 20a (100 mg, 0.59 mmol, 1.0 equiv) in THF (2 mL) was cannulated into the mixture at the same temperature. After stirring for 15 min, the mixture was brought to r.t. and stirred for 12 h. The mixture was then quenched with sat. aq NH4Cl and extracted with Et2O. The combined organic extracts were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo to give the crude product of 21a (75 mg, 53%; E/Z 4:1) as light-yellow oil.
Ethyl 3-(Silyl)octa-2,7-dienoates 21a,b; General Procedure for the Peterson Olefination Reaction
Ethyl 3-(Silyl)octa-2,7-dienoates 21a,b; General Procedure for the Peterson Olefination Reaction
To a solution of ethyl (trimethylsilyl)acetate (1.3 equiv) in THF (3 mL/mmol) was added 1.0 M LiHMDS in THF (1.2 equiv) at –78 °C under argon. After stirring for 20 min at –78 °C, a solution of acylsilane 20a or 20b (1.0 equiv) in THF (2 mL/mmol) was cannulated at –78 °C. The mixture was warmed to 0 °C and stirred for 18 h. The reaction was quenched by the addition of sat. aq NaHCO3 solution and extracted with Et2O. The combined organic extracts were washed with water and brine, dried (Na2SO4), filtered, and concentrated in vacuo to give the crude products as light-yellow oils, which were used in the next step without further purification.
Compound 21a
Following the general procedure using 20a (500 mg, 2.94 mmol) gave 21a; Rf
= 0.63 (silica gel, 5% EtOAc/hexane); E/Z 1:7 (1H NMR of the crude product).
Compound 21b
Following the general procedure using 20b (500 mg, 2.15 mmol) gave 21b; Rf
= 0.53 (silica gel, 5% EtOAc/hexane); E/Z 1:9 (1H NMR of the crude product).
Ethyl (Z)- and (E)-7,8-Epoxy-3-(trimethylsilyl)oct-2-enoates (9a and 9a′)
Ethyl (Z)- and (E)-7,8-Epoxy-3-(trimethylsilyl)oct-2-enoates (9a and 9a′)
To a solution of 21a (500 mg, 2.08 mmol, 1.0 equiv) in CH2Cl2 (10 mL) at 0 °C was added portionwise m-CPBA (77%, 1.16 g, 5.2 mmol, 2.5 equiv). The mixture was warmed to r.t. and stirred for 3 h. The reaction was then quenched with sat. aq Na2SO3 and extracted with Et2O. The combined extracts were washed with sat. aq NaHCO3 solution, water, and brine, dried (anhyd Na2SO4), and concentrated. Purification by flash column chromatography (silica gel, 3% EtOAc/hexane) afforded the epoxide 9a [Z-isomer, 320 mg, 60%; Rf
= 0.46 (silica gel, 8% EtOAc/hexane)] and 9a′ [E-isomer, 52 mg, 10%; Rf
= 0.38 (silica gel, 8% EtOAc/hexane)] as colorless oils.
Ethyl (Z)-7,8-Epoxy-3-(trimethylsilyl)oct-2-enoate (9a)
Ethyl (Z)-7,8-Epoxy-3-(trimethylsilyl)oct-2-enoate (9a)
IR (neat): 2937, 2358, 1717, 1597, 1336, 1250, 1197, 1033, 846 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 6.05–6.02 (m, 1 H), 4.15 (q, J = 7.1 Hz, 2 H), 2.96–2.91 (m, 1 H), 2.76–2.68 (m, 3 H), 2.46 (dd, J = 5.0, 2.7 Hz, 1 H), 1.66–1.52 (m, 4 H), 1.28 (t, J = 7.1 Hz, 3 H), 0.14 (s, 9 H).
13C NMR (CDCl3, 100 MHz): δ = 165.86, 165.28, 126.80, 59.71, 52.07, 47.04, 32.79, 30.94, 26.08, 14.28, –1.83.
HRMS (ESI): m/z [M + Na]+ calcd for C13H24O3SiNa: 279.1392; found: 279.1391.
Ethyl (E)-7,8-Epoxy-3-(trimethylsilyl)oct-2-enoate (9a′)
Ethyl (E)-7,8-Epoxy-3-(trimethylsilyl)oct-2-enoate (9a′)
IR (neat): 2919, 2850, 2362, 2336, 1735, 1644, 1337, 1251, 1199, 1036, 820 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 6.28–6.22 (m, 1 H), 4.15 (q, J = 7.1 Hz, 2 H), 2.98–2.82 (m, 1 H), 2.78–2.72 (m, 1 H), 2.46 (dd, J = 4.9, 2.6 Hz, 1 H), 2.36–2.27 (m, 2 H), 1.65–1.47 (m, 4 H), 1.28 (t, J = 7.1 Hz, 3 H), 0.19 (s, 9 H).
13C NMR (CDCl3, 100 MHz): δ = 166.74, 165.45, 130.34, 60.03, 51.99, 46.99, 38.60, 32.09, 25.89, 14.25, –0.53.
HRMS (ESI): m/z [M + Na]+ calcd for C13H24O3SiNa: 279.1392; found: 279.1391.
Ethyl (Z)- and (E)-3-(Dimethylphenylsilyl)-7,8-epoxyoct-2-enoates (9b and 9b′)
Ethyl (Z)- and (E)-3-(Dimethylphenylsilyl)-7,8-epoxyoct-2-enoates (9b and 9b′)
To a solution of 21b (500 mg, 1.65 mmol, 1.0 equiv) in CH2Cl2 (8 mL) at 0 °C was added portionwise m-CPBA (77%, 924 mg, 4.12 mmol, 2.5 equiv). The mixture was warmed to r.t. and stirred for 3 h. The reaction was then quenched with sat. aq Na2SO3 and extracted with Et2O. The combined extracts were washed with sat. aq NaHCO3 solution, water, and brine, dried (anhyd Na2SO4), and concentrated. Purification by flash column chromatography (silica gel, 3% EtOAc/hexane) afforded the epoxide 9b [Z-isomer, 320 mg, 61%; Rf
= 0.45 (silica gel, 5% EtOAc/hexane)] and 9b′ [E-isomer, 46 mg, 9%; Rf
= 0.33, silica gel (5% EtOAc/hexane)] as colorless oils.
Ethyl (Z)-3-(Dimethylphenylsilyl)-7,8-epoxyoct-2-enoate (9b)
Ethyl (Z)-3-(Dimethylphenylsilyl)-7,8-epoxyoct-2-enoate (9b)
IR (neat): 2981, 2935, 1716, 1597, 1456, 1369, 1336, 1251, 1197, 1109, 1037, 918, 823 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 7.54–7.49 (m, 2 H), 7.34–7.30 (m, 3 H), 6.40–6.36 (m, 1 H), 4.00 (q, J = 7.1 Hz, 2 H), 2.79–2.74 (m, 1 H), 2.70–2.67 (m, 1 H), 2.37 (dd, J = 5.0, 2.6 Hz, 1 H), 2.29–2.24 (m, 2 H), 1.58–1.39 (m, 4 H), 1.15 (t, J = 7.1 Hz, 3 H), 0.51–0.48 (m, 6 H).
13C NMR (CDCl3, 100 MHz): δ = 166.52, 162.59, 138.83, 133.75, 131.75, 128.65, 127.52, 60.08, 51.88, 46.99, 38.90, 32.03, 25.72, 14.07, –1.73.
HRMS (ESI): m/z [M + Na]+ calcd for C18H26O3SiNa: 341.1549; found: 341.1549.
Ethyl (E)-3-(Dimethylphenylsilyl)-7,8-epoxyoct-2-enoate (9b ′)
Ethyl (E)-3-(Dimethylphenylsilyl)-7,8-epoxyoct-2-enoate (9b ′)
IR (neat): 2953, 2929, 1714, 1641, 1600, 1456, 1369, 1340, 1255, 1172, 1111, 1039, 918, 823 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 7.52–7.48 (m, 2 H), 7.41–7.33 (m, 3 H), 6.09 (s, 1 H), 4.15 (q, J = 7.1 Hz, 2 H), 2.83–2.77 (m, 1 H), 2.72–2.64 (m, 3 H), 2.36 (dd, J = 5.0, 2.7 Hz, 1 H), 1.53–1.37 (m, 4 H), 1.28 (t, J = 7.1 Hz, 3 H), 0.45–0.42 (m, 6 H).
13C NMR (CDCl3, 100 MHz): δ = 165.18, 163.89, 136.41, 133.99, 129.47, 128.31, 127.94, 59.82, 51.99, 46.97, 32.65, 31.13, 25.96, 14.26, –3.34, –3.37.
HRMS (ESI): m/z [M + Na]+ calcd for C18H26O3SiNa: 341.1549; found: 341.1549.
cis-6-(Silyl)-3-oxabicyclo[4.3.0]nonan-4-ones (10a and 10b)
cis-6-(Silyl)-3-oxabicyclo[4.3.0]nonan-4-ones (10a and 10b)
Following the general procedure for Cp2TiCl-mediated radical cyclization using 9a/9a′ (100 mg, 0.39 mmol) or 9b (300 mg, 0.94 mmol) gave 10a and 10b, respectively.
cis-6-(Trimethylsilyl)-3-oxabicyclo[4.3.0]nonan-4-one (10a)
cis-6-(Trimethylsilyl)-3-oxabicyclo[4.3.0]nonan-4-one (10a)
Purification by flash column chromatography [100–200 mesh silica gel, 8% EtOAc/hexane; Rf
= 0.47 (silica gel, 16% EtOAc/hexane)] gave 10a as a colorless liquid; yield: 72 mg (84% from 9a); 69 mg, (81% from 9a′).
IR (neat): 2949, 2358, 1745, 1254, 1186, 1023, 843 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 4.11 (d, J = 4.3 Hz, 2 H), 2.42 (d, J = 15.0 Hz, 1 H), 2.33–2.26 (m, 1 H), 2.24 (d, J = 15.0 Hz, 1 H), 1.87–1.62 (m, 4 H), 1.53–1.40 (m, 2 H), 0.03 (s, 9 H).
13C NMR (CDCl3, 100 MHz): δ = 174.24, 70.62, 39.09, 36.71, 36.47, 31.09, 29.26, 25.35, –4.41.
HRMS (ESI): m/z [M + Na]+ calcd for C11H20O2SiNa: 235.1130; found: 235.1132.
cis-6-(Dimethylphenylsilyl)-3-oxabicyclo[4.3.0]nonan-4-one (10b)
cis-6-(Dimethylphenylsilyl)-3-oxabicyclo[4.3.0]nonan-4-one (10b)
Purification by flash column chromatography [100–200 mesh silica gel, 8% EtOAc/hexane; Rf
= 0.46 (silica gel, 20% EtOAc/hexane)] gave 10b as a colorless liquid; yield: 201 mg (78%).
IR (neat): 2953, 1743, 1427, 1382, 1257, 1186, 1112, 1082, 1035, 947, 835 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 7.54–7.50 (m, 2 H), 7.41–7.34 (m, 3 H), 4.04 (dd, J = 11.4, 3.7 Hz, 1 H), 3.83 (dd, J = 11.4, 3.7 Hz, 1 H), 2.47–2.39 (m, 2 H), 2.22 (d, J = 14.9 Hz, 1 H), 1.98–1.89 (m, 1 H), 1.72–1.54 (m, 3 H), 1.50–1.41 (m, 1 H), 1.36–1.24 (m, 1 H), 0.37–0.34 (m, 6 H).
13C NMR (CDCl3, 100 MHz): δ = 174.11, 135.49, 134.24, 129.63, 127.96, 70.49, 39.20, 36.89, 36.79, 30.95, 29.54, 25.32, –6.14, –6.16.
HRMS (ESI): m/z [M + Na]+ calcd for C16H22O2SiNa: 297.1287; found: 297.1285.
cis-6-Hydroxy-3-oxabicyclo[4.3.0]nonan-4-one (6) by Tamao–Fleming Oxidation of the Cycloadduct 10b
cis-6-Hydroxy-3-oxabicyclo[4.3.0]nonan-4-one (6) by Tamao–Fleming Oxidation of the Cycloadduct 10b
To a solution of 10b (200 mg, 0.73 mmol, 1.0 equiv) in CH2Cl2 (10 mL) was added HBF4·OEt2 (1.49 mL, 10.95 mmol, 15.0 equiv) at 0 °C. When the addition was complete, the ice bath was removed, and the mixture was refluxed for 48 h. Then the reaction was quenched by dropwise addition of sat. aq NaHCO3 (at 0 °C). The organic layer was separated and the aqueous layer was extracted with EtOAc. The combined organic extracts were dried (anhyd Na2SO4), filtered, and concentrated under vacuo to give the crude fluorosilane 22, which was dissolved in THF/MeOH (1:1, 14 mL). The solution was cooled to 0 °C and KF (212 mg, 3.65 mmol, 5.0 equiv) and KHCO3 (365 mg, 3.65 mmol, 5.0 equiv) were added followed by 30% aq H2O2 (1.7 mL, 14.6 mmol, 20.0 equiv). The resulting mixture was allowed to warm to r.t. and stirred for 12 h. Then the reaction was quenched with 1 M aq HCl and extracted with EtOAc. The combined organic extracts were dried (anhyd Na2SO4), filtered, and concentrated under reduced pressure. Purification by flash column chromatography [silica gel, 60% EtOAc/hexane; Rf
= 0.33 (silica gel, 80% EtOAc/hexane)] gave the alcohol 6 (106 mg, 93%) as a colorless oil.
IR (neat): 3413, 2955, 2925, 2866, 2362, 2336, 1736, 1388, 1257, 1180, 1060, 1033 cm–1.
1H NMR (CDCl3, 400 MHz): δ = 4.38 (dd, J = 11.6, 5.4 Hz, 1 H), 3.92 (dd, J = 11.6, 7.6 Hz, 1 H), 2.75 (d, J = 14.9 Hz, 1 H), 2.67 (d, J = 14.9 Hz, 1 H), 2.54 (br s, 1 H), 2.34–2.26 (m, 1 H), 2.11–2.00 (m, 1 H), 1.95–1.86 (m, 1 H), 1.85–1.74 (m, 1 H), 1.73–1.61 (m, 2 H), 1.40–1.29 (m, 1 H).
13C NMR (CDCl3, 100 MHz): δ = 172.27, 80.18, 69.52, 46.75, 43.16, 42.75, 29.16, 24.59.
1H NMR (DMSO-d
6, 400 MHz): δ = 5.01 (s, 1 H), 4.26 (dd, J = 11.4, 5.8 Hz, 1 H), 3.89 (dd, J = 11.4, 9.2 Hz, 1 H), 2.68 (d, J = 14.6 Hz, 1 H), 2.52 (d, J = 14.6 Hz, 1 H), 2.15–2.06 (m, 1 H), 1.93–1.83 (m, 1 H), 1.76–1.68 (m, 1 H), 1.68–1.44 (m, 3 H), 1.22–1.13 (m, 1 H).
13C NMR (DMSO-d
6, 100 MHz): δ = 172.65, 79.58, 69.41, 46.63, 43.34, 42.57, 28.88, 24.81.
HRMS (ESI): m/z [M + Na]+ calcd for C8H12O3Na: 179.0684; found: 179.0681.
